GLP-1 weight loss injections are the most significant development in obesity medicine in a generation. In the UK, demand has outpaced supply, waiting lists have formed, and the medications are being prescribed privately at a rate that is transforming the weight management landscape. This guide covers everything you need to know about GLP-1 injections in the UK — how they work, what is available, how to access them, what they cost, and what to expect.
How GLP-1 injections work
GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in the gut after eating. It signals to the brain to reduce appetite, slows gastric emptying, stimulates insulin secretion, and reduces glucagon release. GLP-1 receptor agonists — the medication class — mimic or amplify these effects, producing sustained appetite suppression and improved metabolic function.
| Medication | Active ingredient | Mechanism | Primary UK indication |
|---|---|---|---|
| Mounjaro | Tirzepatide | Dual GLP-1 + GIP agonist | Type 2 diabetes and weight management |
| Wegovy | Semaglutide 2.4mg | GLP-1 agonist | Chronic weight management |
| Ozempic | Semaglutide 1mg | GLP-1 agonist | Type 2 diabetes (used off-label for weight) |
What results to expect
| Medication | Average weight loss | Maximum dose | Time to results |
|---|---|---|---|
| Mounjaro (15mg) | 22.5% body weight (72 weeks) | 15mg weekly | 2–4 weeks for appetite effect; peak at 12–18 months |
| Wegovy (2.4mg) | 14.9% body weight (68 weeks) | 2.4mg weekly | 2–4 weeks for appetite effect; peak at 12–18 months |
| Ozempic (1mg) | ~6–8% body weight (off-label use) | 1mg weekly (diabetes dose) | Similar timeline; lower maximum dose limits weight loss |
UK access — NHS vs private
NHS access
| Medication | NHS criteria | Reality in 2026 |
|---|---|---|
| Wegovy (semaglutide) | BMI ≥35 with weight-related comorbidity OR BMI 30–35 in high-risk groups; specialist referral typically required | NICE-approved; NHS England rollout progressing; significant waiting lists remain |
| Mounjaro (tirzepatide) | Type 2 diabetes management primarily; some specialist obesity services | More restricted than Wegovy for weight management specifically |
Private access
Private weight management services in the UK offer GLP-1 prescriptions without the NHS wait, typically requiring:
- BMI ≥30 (some services ≥27 with comorbidities)
- Completion of a medical questionnaire
- Video or online consultation with a prescriber
- Monthly subscription for ongoing supply and monitoring
UK private services: Numan, Juniper, Voy, Oviva, Manual (and others). Prices vary — compare carefully and verify GMC-registered prescribers and UK-registered pharmacies.
Cost breakdown UK (2026 estimates)
| Service type | Mounjaro cost | Wegovy cost | Notes |
|---|---|---|---|
| NHS prescription (if eligible) | Standard prescription fee (~£9.90) | Standard prescription fee (~£9.90) | Eligibility criteria strict; waiting times variable |
| Private prescription (monthly) | ~£100–160/month | ~£200–250/month | Includes medication; consultation fees may be additional |
| Private (annual estimate) | ~£1,200–2,000 | ~£2,400–3,000 | Cost reduces as dose titrates; varies by provider |
What happens when you start GLP-1 medication
The titration schedule (Mounjaro example)
| Month | Dose | What to expect |
|---|---|---|
| Month 1 | 2.5mg weekly | Mild appetite reduction; possible mild nausea; minimal side effects at starting dose |
| Month 2 | 5mg weekly | More pronounced appetite suppression; nausea may increase at dose change |
| Month 3 | 7.5mg weekly | Significant appetite suppression in most people; dose escalation side effects settling |
| Month 4 | 10mg weekly | Therapeutic dose range; most people experience maximum appetite suppression |
| Month 5+ | 12.5mg or 15mg | Maximum dose; side effects from dose increases typically resolve within 2–4 weeks |
Nutritional support on GLP-1 medication
The appetite suppression of GLP-1 medication creates nutritional gaps that require active management:
The Lily & Loaf Daily Essentials Bundle was specifically designed for this population — combining protein (Daily Fuel), omega-3s (Daily Balance), and probiotics (Daily Flora) in one monthly purchase to cover the three most significant nutritional gaps created by GLP-1 medication.
Lily & Loaf — Recommended
Daily Essentials Bundle
✅ 90-day money-back guarantee | ✅ Free UK delivery over £40
Designed for GLP-1 users — protein + omega + probiotics
Frequently Asked Questions
What GLP-1 injections are available in the UK?
The main GLP-1 weight loss injections available in the UK are Mounjaro (tirzepatide), Wegovy (semaglutide 2.4mg), and Ozempic (semaglutide 1mg, primarily for diabetes but used off-label for weight). Liraglutide (Victoza/Saxenda) is older and less commonly prescribed now.
Can I get GLP-1 injections on the NHS?
Wegovy is NICE-approved for NHS prescription for adults with BMI ≥35 and at least one weight-related comorbidity, or BMI 30–35 in specific high-risk groups. NHS rollout is ongoing but waiting lists exist in most areas. Private prescription is an alternative without waiting lists but at significant cost.
How do I inject Mounjaro?
Mounjaro comes in a pre-filled autoinjector pen. Inject once weekly into the abdomen, thigh, or upper arm — rotate sites to reduce injection reactions. Inject slowly and smoothly. Allow the pen to reach room temperature before injecting. Follow the instructions provided with the medication.
Do GLP-1 injections work long-term?
SURMOUNT-4 showed significant weight regain after stopping Mounjaro — 14% of body weight regained within 12 months of discontinuation. GLP-1 medications address the biological mechanisms of obesity; they do not cure it. Long-term use with lifestyle support produces the best sustained outcomes.
Are GLP-1 injections safe?
GLP-1 medications have been used in type 2 diabetes management for over 15 years. The additional weight management evidence is from clinical trials involving tens of thousands of participants. Common side effects are primarily gastrointestinal and manageable. Serious side effects (pancreatitis, thyroid effects) are rare. Appropriate medical supervision is essential.
Related: Mounjaro vs Wegovy UK | GLP-1 Side Effects UK | Best Supplements on Mounjaro UK
Discover more from Healthy Weight Loss GLP1
Subscribe to get the latest posts sent to your email.
